Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: A patient multidimensional health assessment questionnaire and physician estimate of noninflammatory symptoms

Journal of Rheumatology

Volumn 38, Issue 7, 2011, Pages 1309-1316

  Askanase, Anca Dinu ^a   Castrejón, Isabel ^a   Pincus, Theodore ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Assessment; Index; Multidimensional health assessment questionnaire; Systemic lupus activity questionnaire; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MALE; MEDICAL PRACTICE; MULTIDIMENSIONAL HEALTH ASSESSMENT QUESTIONNAIRE; PATIENT CARE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ROUTINE ASSESSMENT OF PATIENT INDEX DATA 3; SCORING SYSTEM; SYMPTOMATOLOGY; SYSTEMIC LUPUS ACTIVITY QUESTIONNAIRE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FATIGUE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 79960023269     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.101091     Document Type: Article

References (45)

1. Goldsmith CH, Smythe HA, Helewa A. Interpretation and power of pooled index. J Rheumatol 1993;20:575-8.
2. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
3. Hawker G, Gabriel S, Bombardier C, Goldsmith C, Caron D, Gladman D. A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus. J Rheumatol 1993;20:657-60. (Pubitemid 23138854)
4. Petri M, Buyon J, Kim M. Classification and definition of major flares in SLE clinical trials. Lupus 1999;8:685-91. (Pubitemid 29520536)
5. Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005;142:953-62.
6. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005;353:2550-8. (Pubitemid 41785892)
7. Gladman DD, Ibanez D, Urowitz MB. Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 2002;29:288-91.
8. Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993;86:447-58. (Pubitemid 23223653)
9. Isenberg DA, Rahman A, Allen E, Farewell V, Akil M, Bruce IN, et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology 2005;44:902-6.
10. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18. (Pubitemid 19237865)
11. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992;10:541-7.
12. Hampton JR, Harrison MJG, Mitchell JRA, Prichard JS, Seymour C. Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J 1975;2:486-9.
13. Peterson MC, Holbrook JH, Hales DV, Smith NL, Staker LV. Contributions of the history, physical examination, and laboratory investigation in marking medical diagnoses. West J Med 1992;56:163-5.
14. Pryor DB, Shaw L, McCants CB, Lee KL, Mark DB, Harrell FE Jr, et al. Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med 1993;118:81-90.
15. Sandler G. The importance of the history in the medical clinic and the cost of unnecessary tests. Am Heart J 1980;100:928-31. (Pubitemid 11198888)
16. Karlson EW, Daltroy LH, Rivest C, Ramsey-Goldman R, Wright EA, Partridge AJ, et al. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus 2003;12:280-6. (Pubitemid 36458658)
17. Pincus T, Bergman MJ, Maclean R, Yazici Y. Complex measures and indices for clinical research compared with simple patient questionnaires to assess function, pain, and global estimates as rheumatology "vital signs" for usual clinical care. Rheum Dis Clin North Am 2009;35:779-86.
18. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45. (Pubitemid 10164318)
19. Pincus T, Swearingen C, Wolfe F. Toward a Multidimensional Health Assessment Questionnaire (MDHAQ): Assessment of advanced activities of daily living and psychological status in the patient friendly health assessment questionnaire format. Arthritis Rheum 1999;42:2220-30. (Pubitemid 30263609)
20. Pincus T, Sokka T, Kautiainen H. Further development of a physical function scale on a Multidimensional Health Assessment Questionnaire for standard care of patients with rheumatic diseases. J Rheumatol 2005;32:1432-9. (Pubitemid 41113961)
21. Pincus T, Bergman MJ, Yazici Y, Hines P, Raghupathi K, Maclean R. An index of only patient-reported outcome measures, Routine Assessment of Patient Index Data 3 (RAPID3), in two abatacept clinical trials: similar results to Disease Activity Score (DAS28) and other RAPID indices that include physician-reported measures. Rheumatology 2008;47:345-9.
22. Pincus T, Swearingen CJ, Bergman MJ, Colglazier CL, Kaell A, Kunath A, et al. RAPID3 on an MDHAQ is correlated significantly with activity levels of DAS28 and CDAI, but scored in 5 versus more than 90 seconds. Arthritis Care Res 2010;62:181-9.
23. Pincus T, Swearingen CJ. The HAQ compared with the MDHAQ: "keep it simple, stupid" (KISS), with feasibility and clinical value as primary criteria for patient questionnaires in usual clinical care. Rheum Dis Clin North Am 2009;35:787-98.
24. Pincus T, Sokka T. Can a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores be informative in patients with all rheumatic diseases? Best Pract Res Clin Rheumatol 2007;21:733-53.
25. Pincus T, Askanase AD, Swearingen CJ. A Multi-dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID3) scores are informative in patients with all rheumatic diseases. Rheum Dis Clin North Am 2009;35:819-27.
26. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7. (Pubitemid 13221242)
27. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
28. Pincus T, Yazici Y, Bergman MJ. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care. Rheum Dis Clin North Am 2009;35:773-8.
29. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1998.
30. Cupples LA, Heeren T, Schatzkin A, Colton T. Multiple testing of hypotheses in comparing two groups. Ann Intern Med 1984;100:122-9. (Pubitemid 14219141)
31. Pincus T, Sokka T. Quantitative clinical rheumatology: "keep it simple, stupid": MDHAQ function, pain, global, and RAPID3 quantitative scores to improve and document the quality of rheumatologic care. J Rheumatol 2009;36:1099-100.
32. Petri M. Disease activity assessment in SLE: do we have the right instruments? Ann Rheum Dis 2007;66 Suppl 3:iii61-iii64.
33. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia - Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72. (Pubitemid 20098653)
34. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010;62:600-10.
35. Croft P, Rigby AS, Boswell R, Schollum J, Silman A. The prevalence of chronic widespread pain in the general population. J Rheumatol 1993;20:710-3. (Pubitemid 23138864)
36. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
37. Callahan LF, Pincus T. The P-VAS/D-ADL ratio: A clue from a self-report questionnaire to distinguish rheumatoid arthritis from noninflammatory diffuse musculoskeletal pain. Arthritis Rheum 1990;33:1317-22. (Pubitemid 20365562)
38. DeWalt DA, Reed GW, Pincus T. Further clues to recognition of patients with fibromyalgia from a simple 2-page patient Multidimensional Health Assessment Questionnaire (MDHAQ). Clin Exp Rheumatol 2004;22:453-61. (Pubitemid 39089806)
39. Yen JC, Neville C, Fortin PR. Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trials. Lupus 1999;8:660-70. (Pubitemid 29520533)
40. Alarcon GS, McGwin G Jr, Brooks K, Roseman JM, Fessler BJ, Sanchez ML, et al. Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: a comparison of physician and patient visual analog scale scores. Arthritis Rheum 2002;47:408-13.
41. Leong KP, Chong E, Kong K, Chan S, Thong B, Lian T, et al. Discordant assessment of lupus activity between patients and their physicians: the Singapore experience. Lupus 2010;19:100-6.
42. Pincus T, Amara I, Segurado OG, Bergman M, Koch GG. Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials. J Rheumatol 2008;35:201-5. (Pubitemid 351284437)
43. Pincus T, Hassett AL, Callahan LF. Clues on the MDHAQ to identify patients with fibromyalgia and similar chronic pain conditions. Rheum Dis Clin North Am 2009;35:865-9.
44. Pincus T, Bergman MJ. Quantitative recording of physician clinical estimates, beyond a global estimate and formal joint count, in usual care: applying the scientific method, using a simple one-page worksheet. Rheum Dis Clin North Am 2009;35:813-7.
45. Pincus T, Yazici Y, Swearingen CJ. Quality control of a medical history: improving accuracy with patient participation, supported by a four-page version of the Multidimensional Health Assessment Questionnaire (MDHAQ). Rheum Dis Clin North Am 2009;35:851-60.